EXPLAINER: $26B opioid settlement big step, but not the end


              FILE - This Aug. 29, 2018, file photo shows an arrangement of Oxycodone pills in New York. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Mark Lennihan, File)
            
              FILE - In this Feb. 24, 2021, file photo, Johnson & Johnson logo appears on the exterior of a first aid kit in Walpole, Mass. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Steven Senne, File)